Brighten Optix Corporation (TPEX:6747)
Taiwan · Delayed Price · Currency is TWD 198.50
0.00 (0.00%)
Oct 31, 2025, 2:31 PM CST
Brighten Optix Market Cap
Brighten Optix has a market cap or net worth of 5.4 billion as of October 31, 2025. Its market cap has increased by 28.90% in one year.
Market Cap
5.40B
Enterprise Value
5.00B
Revenue
778.00M
Ranking
n/a
PE Ratio
87.62
Stock Price
198.50
Market Cap Chart
Since October 7, 2019, Brighten Optix's market cap has increased from 2.82B to 5.40B, an increase of 91.75%. That is a compound annual growth rate of 11.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 5.40B | 49.25% |
| Dec 31, 2024 | 3.62B | -21.08% |
| Dec 29, 2023 | 4.58B | 1.61% |
| Dec 30, 2022 | 4.51B | -37.73% |
| Dec 30, 2021 | 7.24B | 133.55% |
| Dec 31, 2020 | 3.10B | 6.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |